Suchergebnisse - "Oster, Howard S"

PubPharm (42)

1

Validation of a novel algorithm with a high specificity in ruling out MDS

enthalten in: International journal of laboratory hematology | 2024

von Schulz, F. | Nachtkamp, K. | Oster, H. | +5

2

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level

enthalten in: Journal of clinical medicine | 2023

von Haring, Y. | Goldschmidt, N. | Taha, S. | +20

3

Routine Inflammatory Markers Are Elevated in Myelodysplastic Syndromes at Presentation

enthalten in: Mediterranean journal of hematology and infectious diseases | 2023

von Oster, H. | Sklyar, E. | Golsdshmidt, N. | +1

4

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting

enthalten in: Blood | 2022

von Mittelman, M. | Magen, O. | Barda, N. | +4

CommentIn: Blood. 2022 Mar 10;139(10):1429-1430. - PMID 35267005

5

Serum Hypoalbuminemia Is a Long-Term Prognostic Marker in Medical Hospitalized Patients, Irrespective of the Underlying Disease

enthalten in: Journal of clinical medicine | 2022

von Oster, H. | Dolev, Y. | Kehat, O. | +2

6

Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes - A potential prognostic marker?

enthalten in: Frontiers in oncology | 2022

von Book, R. | Ben-Ezra, J. | Glait Santar, C. | +4

7

Unraveling a Nosocomial Outbreak of COVID-19 : The Role of Whole-Genome Sequence Analysis

enthalten in: Open forum infectious diseases | 2021

von Meijer, S. | Harel, N. | Ben-Ami, R. | +9

8

A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS

enthalten in: Blood advances | 2021

von Oster, H. | Crouch, S. | Smith, A. | +26

9

Thrombocytopenia in myelodysplastic syndromes : time to lift the embargo on thrombomimetics?

enthalten in: British journal of haematology | 2021

von Mittelman, M. | Oster, H.

CommentOn: Br J Haematol. 2021 Jul;194(2):336-343. - PMID 34151423

10

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic Patients

enthalten in: Acta haematologica | 2021

von Oster, H. | Gvili Perelman, M. | Kolomansky, A. | +2

1
2
3
4
5
Nächster »
[5]